Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Gu?rin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme
This report contains market size and forecasts of Tuberculosis Vaccination in global, including the following market information:
Global Tuberculosis Vaccination Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Tuberculosis Vaccination Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Tuberculosis Vaccination companies in 2021 (%)
The global Tuberculosis Vaccination market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Immune Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Tuberculosis Vaccination include Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin and Taj Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Publishers has surveyed the Tuberculosis Vaccination manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tuberculosis Vaccination Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Tuberculosis Vaccination Market Segment Percentages, by Type, 2021 (%)
Immune Vaccine
Therapy Vaccine
Global Tuberculosis Vaccination Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Tuberculosis Vaccination Market Segment Percentages, by Application, 2021 (%)
Self-Procurement
UNICEF
Other
Global Tuberculosis Vaccination Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Tuberculosis Vaccination Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tuberculosis Vaccination revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Tuberculosis Vaccination revenues share in global market, 2021 (%)
Key companies Tuberculosis Vaccination sales in global market, 2017-2022 (Estimated), (Units)
Key companies Tuberculosis Vaccination sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC - Institute of Vaccines and Medical Biologicals
Queen Saovabha Mem. Inst
Microgen
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Tuberculosis Vaccination Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tuberculosis Vaccination Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tuberculosis Vaccination Overall Market Size
2.1 Global Tuberculosis Vaccination Market Size: 2021 VS 2028
2.2 Global Tuberculosis Vaccination Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Tuberculosis Vaccination Sales: 2017-2028
3 Company Landscape
3.1 Top Tuberculosis Vaccination Players in Global Market
3.2 Top Global Tuberculosis Vaccination Companies Ranked by Revenue
3.3 Global Tuberculosis Vaccination Revenue by Companies
3.4 Global Tuberculosis Vaccination Sales by Companies
3.5 Global Tuberculosis Vaccination Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Tuberculosis Vaccination Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Tuberculosis Vaccination Product Type
3.8 Tier 1, Tier 2 and Tier 3 Tuberculosis Vaccination Players in Global Market
3.8.1 List of Global Tier 1 Tuberculosis Vaccination Companies
3.8.2 List of Global Tier 2 and Tier 3 Tuberculosis Vaccination Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Tuberculosis Vaccination Market Size Markets, 2021 & 2028
4.1.2 Immune Vaccine
4.1.3 Therapy Vaccine
4.2 By Type - Global Tuberculosis Vaccination Revenue & Forecasts
4.2.1 By Type - Global Tuberculosis Vaccination Revenue, 2017-2022
4.2.2 By Type - Global Tuberculosis Vaccination Revenue, 2023-2028
4.2.3 By Type - Global Tuberculosis Vaccination Revenue Market Share, 2017-2028
4.3 By Type - Global Tuberculosis Vaccination Sales & Forecasts
4.3.1 By Type - Global Tuberculosis Vaccination Sales, 2017-2022
4.3.2 By Type - Global Tuberculosis Vaccination Sales, 2023-2028
4.3.3 By Type - Global Tuberculosis Vaccination Sales Market Share, 2017-2028
4.4 By Type - Global Tuberculosis Vaccination Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Tuberculosis Vaccination Market Size, 2021 & 2028
5.1.2 Self-Procurement
5.1.3 UNICEF
5.1.4 Other
5.2 By Application - Global Tuberculosis Vaccination Revenue & Forecasts
5.2.1 By Application - Global Tuberculosis Vaccination Revenue, 2017-2022
5.2.2 By Application - Global Tuberculosis Vaccination Revenue, 2023-2028
5.2.3 By Application - Global Tuberculosis Vaccination Revenue Market Share, 2017-2028
5.3 By Application - Global Tuberculosis Vaccination Sales & Forecasts
5.3.1 By Application - Global Tuberculosis Vaccination Sales, 2017-2022
5.3.2 By Application - Global Tuberculosis Vaccination Sales, 2023-2028
5.3.3 By Application - Global Tuberculosis Vaccination Sales Market Share, 2017-2028
5.4 By Application - Global Tuberculosis Vaccination Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Tuberculosis Vaccination Market Size, 2021 & 2028
6.2 By Region - Global Tuberculosis Vaccination Revenue & Forecasts
6.2.1 By Region - Global Tuberculosis Vaccination Revenue, 2017-2022
6.2.2 By Region - Global Tuberculosis Vaccination Revenue, 2023-2028
6.2.3 By Region - Global Tuberculosis Vaccination Revenue Market Share, 2017-2028
6.3 By Region - Global Tuberculosis Vaccination Sales & Forecasts
6.3.1 By Region - Global Tuberculosis Vaccination Sales, 2017-2022
6.3.2 By Region - Global Tuberculosis Vaccination Sales, 2023-2028
6.3.3 By Region - Global Tuberculosis Vaccination Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Tuberculosis Vaccination Revenue, 2017-2028
6.4.2 By Country - North America Tuberculosis Vaccination Sales, 2017-2028
6.4.3 US Tuberculosis Vaccination Market Size, 2017-2028
6.4.4 Canada Tuberculosis Vaccination Market Size, 2017-2028
6.4.5 Mexico Tuberculosis Vaccination Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Tuberculosis Vaccination Revenue, 2017-2028
6.5.2 By Country - Europe Tuberculosis Vaccination Sales, 2017-2028
6.5.3 Germany Tuberculosis Vaccination Market Size, 2017-2028
6.5.4 France Tuberculosis Vaccination Market Size, 2017-2028
6.5.5 U.K. Tuberculosis Vaccination Market Size, 2017-2028
6.5.6 Italy Tuberculosis Vaccination Market Size, 2017-2028
6.5.7 Russia Tuberculosis Vaccination Market Size, 2017-2028
6.5.8 Nordic Countries Tuberculosis Vaccination Market Size, 2017-2028
6.5.9 Benelux Tuberculosis Vaccination Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Tuberculosis Vaccination Revenue, 2017-2028
6.6.2 By Region - Asia Tuberculosis Vaccination Sales, 2017-2028
6.6.3 China Tuberculosis Vaccination Market Size, 2017-2028
6.6.4 Japan Tuberculosis Vaccination Market Size, 2017-2028
6.6.5 South Korea Tuberculosis Vaccination Market Size, 2017-2028
6.6.6 Southeast Asia Tuberculosis Vaccination Market Size, 2017-2028
6.6.7 India Tuberculosis Vaccination Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Tuberculosis Vaccination Revenue, 2017-2028
6.7.2 By Country - South America Tuberculosis Vaccination Sales, 2017-2028
6.7.3 Brazil Tuberculosis Vaccination Market Size, 2017-2028
6.7.4 Argentina Tuberculosis Vaccination Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Tuberculosis Vaccination Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Tuberculosis Vaccination Sales, 2017-2028
6.8.3 Turkey Tuberculosis Vaccination Market Size, 2017-2028
6.8.4 Israel Tuberculosis Vaccination Market Size, 2017-2028
6.8.5 Saudi Arabia Tuberculosis Vaccination Market Size, 2017-2028
6.8.6 UAE Tuberculosis Vaccination Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Tuberculosis Vaccination Major Product Offerings
7.1.4 Merck Tuberculosis Vaccination Sales and Revenue in Global (2017-2022)
7.1.5 Merck Key News
7.2 Japan BCG Lab
7.2.1 Japan BCG Lab Corporate Summary
7.2.2 Japan BCG Lab Business Overview
7.2.3 Japan BCG Lab Tuberculosis Vaccination Major Product Offerings
7.2.4 Japan BCG Lab Tuberculosis Vaccination Sales and Revenue in Global (2017-2022)
7.2.5 Japan BCG Lab Key News
7.3 Serum Institute of India
7.3.1 Serum Institute of India Corporate Summary
7.3.2 Serum Institute of India Business Overview
7.3.3 Serum Institute of India Tuberculosis Vaccination Major Product Offerings
7.3.4 Serum Institute of India Tuberculosis Vaccination Sales and Revenue in Global (2017-2022)
7.3.5 Serum Institute of India Key News
7.4 AJ Vaccines
7.4.1 AJ Vaccines Corporate Summary
7.4.2 AJ Vaccines Business Overview
7.4.3 AJ Vaccines Tuberculosis Vaccination Major Product Offerings
7.4.4 AJ Vaccines Tuberculosis Vaccination Sales and Revenue in Global (2017-2022)
7.4.5 AJ Vaccines Key News
7.5 BioFarma
7.5.1 BioFarma Corporate Summary
7.5.2 BioFarma Business Overview
7.5.3 BioFarma Tuberculosis Vaccination Major Product Offerings
7.5.4 BioFarma Tuberculosis Vaccination Sales and Revenue in Global (2017-2022)
7.5.5 BioFarma Key News
7.6 GreenSignal Bio Pharma
7.6.1 GreenSignal Bio Pharma Corporate Summary
7.6.2 GreenSignal Bio Pharma Business Overview
7.6.3 GreenSignal Bio Pharma Tuberculosis Vaccination Major Product Offerings
7.6.4 GreenSignal Bio Pharma Tuberculosis Vaccination Sales and Revenue in Global (2017-2022)
7.6.5 GreenSignal Bio Pharma Key News
7.7 China National Biotec
7.7.1 China National Biotec Corporate Summary
7.7.2 China National Biotec Business Overview
7.7.3 China National Biotec Tuberculosis Vaccination Major Product Offerings
7.7.4 China National Biotec Tuberculosis Vaccination Sales and Revenue in Global (2017-2022)
7.7.5 China National Biotec Key News
7.8 Biomed Lublin
7.8.1 Biomed Lublin Corporate Summary
7.8.2 Biomed Lublin Business Overview
7.8.3 Biomed Lublin Tuberculosis Vaccination Major Product Offerings
7.8.4 Biomed Lublin Tuberculosis Vaccination Sales and Revenue in Global (2017-2022)
7.8.5 Biomed Lublin Key News
7.9 Taj Pharmaceuticals
7.9.1 Taj Pharmaceuticals Corporate Summary
7.9.2 Taj Pharmaceuticals Business Overview
7.9.3 Taj Pharmaceuticals Tuberculosis Vaccination Major Product Offerings
7.9.4 Taj Pharmaceuticals Tuberculosis Vaccination Sales and Revenue in Global (2017-2022)
7.9.5 Taj Pharmaceuticals Key News
7.10 Ataulpho de Paiva
7.10.1 Ataulpho de Paiva Corporate Summary
7.10.2 Ataulpho de Paiva Business Overview
7.10.3 Ataulpho de Paiva Tuberculosis Vaccination Major Product Offerings
7.10.4 Ataulpho de Paiva Tuberculosis Vaccination Sales and Revenue in Global (2017-2022)
7.10.5 Ataulpho de Paiva Key News
7.11 IVAC